ArticleKorean journal of radiology2023
Value of Intraplaque Neovascularization on Contrast-Enhanced Ultrasonography in Predicting Ischemic Stroke Recurrence in Patients With Carotid Atherosclerotic Plaque.
Article in Korean journal of radiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 10 citations in OpenAlex.
- Contrast-enhanced ultrasound for reclassification of moderate-risk carotid plaques (Plaque-RADS 3).BMC medical imaging · 2026Article
- Dual-modal ultrasound radiomics model enhances identification of symptomatic carotid plaque: a multicenter retrospective study.The international journal of cardiovascular imaging · 2026Article
- Contrast-enhanced ultrasound detection of a longitudinal fissure-like intraplaque channel associated with plaque-fragment embolization during carotid artery stenting: a case report.Frontiers in cardiovascular medicine · 2026Article
- Multimodal Radiomics Model Combining HR-VWI and Clinical Features for Identifying Symptomatic Basilar Atherosclerotic Plaques.BioMed research international · 2026Article
- Improved stroke risk stratification in carotid atherosclerosis: integrating intraplaque neovascularization into Carotid Plaque-RADS.BMC medical imaging · 2025Article
- Predictive value of contrast-enhanced ultrasound in assessing the risk of recurrent in ipsilateral anterior circulation ischemic stroke.BMC medical imaging · 2025Article
- Independent predictors of ischemic stroke: a comprehensive scan of the internal carotid and vertebrobasilar systems.Quantitative imaging in medicine and surgery · 2025Article
- Prediction of ischemic stroke in elderly hypertensive patients using carotid plaque superb microvascular imaging characteristics: a lasso-logistic regression model.Journal of medical ultrasonics (2001) · 2025Article
- Incremental clinical value of intraplaque neovascularization in predicting recurrent ischemic stroke.Annals of clinical and translational neurology · 2025Article
- Risk prediction for symptomatic ischemic cerebrovascular disease based on ultrasound indicators of carotid plaque neovascularization.Frontiers in cardiovascular medicine · 2025Article
- What Is the Added Value of Carotid CEUS in the Characterization of Atherosclerotic Plaque?Medicina (Kaunas, Lithuania) · 2024Review
- Before Plaque Enhancement Can Predict Stroke Recurrence, Alternative Etiologies Must Be Off the Table.Korean journal of radiology · 2023Article
Corrections and comments
- Commented on by
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivePatients with a history of ischemic stroke are at risk for a second ischemic stroke. This study aimed to investigate the relationship between carotid plaque enhancement on perfluorobutane microbubble contrast-enhanced ultrasonography (CEUS) and future recurrent stroke, and to determine whether plaque enhancement can contribute to risk assessment for recurrent stroke compared with the Essen Stroke Risk Score (ESRS). MATERIALS AND
methodsThis prospective study screened 151 patients with recent ischemic stroke and carotid atherosclerotic plaques at our hospital between August 2020 and December 2020. A total of 149 eligible patients underwent carotid CEUS, and 130 patients who were followed up for 15-27 months or until stroke recurrence were analyzed. Plaque enhancement on CEUS was investigated as a possible risk factor for stroke recurrence and as a possible adjunct to ESRS.
resultsDuring follow-up, 25 patients (19.2%) experienced recurrent stroke. Patients with plaque enhancement on CEUS had an increased risk of stroke recurrence events (22/73, 30.1%) compared to those without plaque enhancement (3/57, 5.3%), with an adjusted hazard ratio (HR) of 38.264 (95% confidence interval [CI]:14.975-97.767;
conclusionCarotid plaque enhancement was a significant and independent predictor of stroke recurrence in patients with ischemic stroke. Furthermore, the addition of plaque enhancement improved the risk stratification capability of the ESRS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.